Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ashler et MansonXPAR:MLAEM 80 Return-on-Tangible-Equity is 4.74% as of Dec. 2024, which is 113% above its 10-year median of 2.23. GuruFocus rates XPAR:MLAEM with a GF Score™ of 80/100 and a GF Value™ of €2.62 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 497 Insurance companies, Ashler et Manson ranks worse than 81.49% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Ashler et Manson's annualized net income for the quarter that ended in Dec. 2024 was €0.06 Mil. Ashler et Manson's average shareholder tangible equity for the quarter that ended in Dec. 2024 was €1.33 Mil. Therefore, Ashler et Manson's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2024 was 4.74%.
The historical rank and industry rank for Ashler et Manson's Return-on-Tangible-Equity or its related term are showing as below:
XPAR:MLAEM'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -12.3 Med: 2.23 Max: 11.4
Current: 4.74
During the past 10 years, Ashler et Manson's highest Return-on-Tangible-Equity was 11.40%. The lowest was -12.30%. And the median was 2.23%.
XPAR:MLAEM's Return-on-Tangible-Equity is ranked worse than 81.49% of 497
companies
in the Insurance industry
Industry Median: 13.32
vs XPAR:MLAEM: 4.74
Ashler et Manson (XPAR:MLAEM) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Ashler et Manson Return-on-Tangible-Equity Related Terms
Ashler et Manson Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Ashler et Manson's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLAEM vs MRSH, AON, AJG: Return-on-Tangible-Equity Comparison
For the Insurance Brokers subindustry, Ashler et Manson's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ashler et Manson Return-on-Tangible-Equity vs Insurance Industry
For the Insurance industry and Financial Services sector, Ashler et Manson's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Ashler et Manson's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Dec. 2024) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 4.74% mean?
Ashler et Manson (XPAR:MLAEM) has a Return-on-Tangible-Equity of 4.74% as of Dec. 2024. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Ashler et Manson and its competitors. This is 113% above median its historical median of 2.23. According to the industry distribution chart, Ashler et Manson ranks #405 out of 497 companies in the Insurance industry, placing it in the top 81.5%.
Is Ashler et Manson's Return-on-Tangible-Equity too high?
Ashler et Manson's current Return-on-Tangible-Equity of 4.74% is 113% above median its 10-year median of 2.23. The Insurance industry median Return-on-Tangible-Equity is 13.32. Ashler et Manson's value of 4.74% is 64.4% below this industry median. Based on the distribution chart, Ashler et Manson ranks #405 out of 497 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Ashler et Manson has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ashler et Manson's Return-on-Tangible-Equity compare to MRSH and AON?
According to the Insurance industry distribution chart, Ashler et Manson ranks #405 out of 497 companies for Return-on-Tangible-Equity. This places Ashler et Manson in the lower half of its industry. The industry median Return-on-Tangible-Equity is 13.32. Ashler et Manson's value of 4.74% is 64.4% below this benchmark. While the company's 10-year median is 2.23 vs. the industry median of 13.32, Ashler et Manson has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for an Insurance company?
The median Return-on-Tangible-Equity among Insurance companies is 13.32, based on 497 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ashler et Manson's current Return-on-Tangible-Equity of 4.74% is 64.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Ashler et Manson and its competitors. For the Insurance industry, the median Return-on-Tangible-Equity is 13.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ashler et Manson's current Return-on-Tangible-Equity is 4.74%, which is 113% above median its own 10-year median of 2.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ashler et Manson stock overvalued right now?
Based on GuruFocus' analysis, Ashler et Manson (XPAR:MLAEM) is currently considered Modestly Overvalued. The stock's GF Value™ is €2.62, compared to a current price of €3.04 — trading 16% above its estimated fair value. The current Return-on-Tangible-Equity is 4.74%, which is 113% above median its 10-year median of 2.23 and 64.4% below the Insurance industry median of 13.32. Ashler et Manson's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Ashler et Manson (XPAR:MLAEM), the current Return-on-Tangible-Equity is 4.74% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ashler et Manson (XPAR:MLAEM) Overvalued in 2026?
Based on GuruFocus' analysis, Ashler et Manson stock appears to be overvalued.
The current stock price of €3.04 is trading 16% above its estimated GF Value™ of €2.62.
GuruFocus considers Ashler et Manson to be Modestly Overvalued.
Key valuation signals for XPAR:MLAEM:
Return-on-Tangible-Equity: 4.74% (113% above median its 10-year median of 2.23)
GF Value™: €2.62 vs. price of €3.04 (16% above fair value)
Industry Position: 64.4% below the Insurance median (#405 of 497)
No single metric tells the full story. See the XPAR:MLAEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLAEM has been successfully added to your 
